[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367349-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367349-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","expression-distribution-and-function-of-the-transient-receptor-potential-vanilloid-type-1-trpv1-in-endometrial-cancer","Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer","","The transient receptor potential vanilloid 1 receptor (TRPV1) is a calcium-sensitive membrane receptor activated by capsaicin and the endocannabinoid anandamide (AEA). This study examines how TRPV1 expression and distribution change in normal versus endometrial cancer (EC) tissues and clarifies in vitro mechanisms underlying reduced EC cell growth. TRPV1 transcript and protein levels were markedly reduced in EC. Ki-67, BAX, and Bcl-2 associations depended on EC subtype, while AEA reduced Ishikawa cell numbers without TRPV1 involvement, suggesting TRPV1 loss contributes to EC aetiopathogenesis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/expression-distribution-and-function-of-the-transient-receptor-potential-vanilloid-type-1-trpv1-in-endometrial-cancer/367349/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/expression-distribution-and-function-of-the-transient-receptor-potential-vanilloid-type-1-trpv1-in-endometrial-cancer/367349.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study focusing on regarding TRPV1 in endometrial cancer?","Question",{"text":63,"@type":64},"The study investigates TRPV1 expression and distribution in normal versus endometrial cancer endometria, then tests how reduced EC cell growth occurs in vitro.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do TRPV1 transcript and protein levels differ between EC and control tissues?",{"text":68,"@type":64},"TRPV1 transcript and immunoreactive protein levels are significantly reduced in EC tissues compared with control (atrophic) endometria, with transcript decreases paralleling near loss of TRPV1 protein.",{"name":70,"@type":61,"acceptedAnswer":71},"Does anandamide inhibit EC cell growth through TRPV1 activation?",{"text":72,"@type":64},"In vitro, AEA decreases Ishikawa cell numbers, while capsaicin does not, indicating AEA’s anti-proliferative effect is unlikely to act via the TRPV1 receptor.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367349,1790904372,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nExpression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer  \nThangesweran Ayakannu 1,2,3,*, Anthony H. Taylor 1,4 and Justin C. Konje 1,5  \nAcademic Editor: David B. Alexander  \nReceived: 23 October 2024  \nRevised: 20 January 2025  \nAccepted: 21 January 2025  \nPublished: 27 March 2025  \nCitation: Ayakannu, T.; Taylor, A.H.; Konje, J.C. Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer. Int. J. Mol. Sci. 2025, 26, 3104. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms26073104](10.3390/ijms26073104)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Endocannabinoid Research Group, Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 7RH, UK; [superdoc.at@gmail.com](superdoc.at@gmail.com) (A.H.T.); [jck4@leicester.ac.uk](jck4@leicester.ac.uk) (J.C.K.)  \n2 Obstetrics & Gynaecology Centre of Excellence, Sunway Medical Centre, Petaling Jaya 47500, Malaysia  \n3 Division of Obstetrics & Gynaecology, Department of Clinical Medicine and Surgery, Sunway University, Petaling Jaya 47500, Malaysia  \n4 Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK  \n5 Department of Health Sciences, University of Leicester, Leicester LE1 7RH, UK  \n* Correspondence: [thangeswerana@sunmed.com.my](thangeswerana@sunmed.com.my); Tel.: +60-(0)012-655-2615  \nAbstract: The transient receptor potential vanilloid 1 receptor (TRPV1) is a calcium-sensitive membrane receptor activated by capsaicin and the endocannabinoid, anandamide (AEA) . Once activated in vitro, endometrial cancer (EC) cell growth appears tobe inhibited through increased apoptosis, but the mechanism remains unclear. Our aim was to investigate the expression and distribution of TRPV1 in normal and cancerous endometria and to determine the precise in vitro mechanism of decreased EC cellular growth. TRPV1 expression inpatients with endometrial carcinoma (15 Type 1 EC, six Type 2 EC) and six normal patients (atrophic endometria) was assessed using quantitative RT-PCR and immunohistochemistry (IHC) . Additionally, immunohistochemical staining for the proliferation marker Ki-67, the pro-apoptotic marker BAX and the anti-apoptotic marker Bcl-2 were explored. TRPV1 transcript (p = 0.0054) and immunoreactive protein (p \u003C 0.0001) levels were significantly reduced in all EC tissues when compared to control (atrophic) endometria. The almost 50% reduction in TRPV1 transcript levels was mirrored by an almost complete loss of immunoreactive TRPV1 protein. The increased proliferation (Ki-67) of EC tissues correlated with the expression of mutated BAX and inversely correlated to Bcl-2, but only in Type 2 EC samples. In vitro, AEA caused a decrease in Ishikawa cell numbers, whilst capsaicin did not, suggesting the anti-proliferative effect of AEA in EC cells is not via the TRPV1 receptor. In conclusion, the loss of TRPV1 expression in vivo plays a role in the aetiopathogenesis of EC. Activation of cells by AEA also probably promotes EC cell loss through a pro-apoptotic mechanism not involving TRPV1 .  \nKeywords: anandamide; apoptosis; cell growth; endocannabinoid; endometrial cancer; vanilloid receptor  \n1. Introduction  \nGlobally, endometrial cancer (EC) has become the most common female gynaecological cancer [1] . In 2020, more than 417,000 new cases were diagnosed and more than 97,000 women died globally from EC [2] . The American Cancer Society estimated that between 63,000 and 69,000 new cases of EC will have been diagnosed in the USA alone and that as man","cbCaimYBA7xzlmqw","https://ap.wps.com/l/cbCaimYBA7xzlmqw","pdf",5126103,23,"English","# Introduction\n## Epidemiology of endometrial cancer\n## Endocannabinoid system and TRPV1 background","[{\"question\":\"What is the study focusing on regarding TRPV1 in endometrial cancer?\",\"answer\":\"The study investigates TRPV1 expression and distribution in normal versus endometrial cancer endometria, then tests how reduced EC cell growth occurs in vitro.\"},{\"question\":\"How do TRPV1 transcript and protein levels differ between EC and control tissues?\",\"answer\":\"TRPV1 transcript and immunoreactive protein levels are significantly reduced in EC tissues compared with control (atrophic) endometria, with transcript decreases paralleling near loss of TRPV1 protein.\"},{\"question\":\"Does anandamide inhibit EC cell growth through TRPV1 activation?\",\"answer\":\"In vitro, AEA decreases Ishikawa cell numbers, while capsaicin does not, indicating AEA’s anti-proliferative effect is unlikely to act via the TRPV1 receptor.\"}]","Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer | PDF",1790170404,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d72239c6ac8db1162fa000a128705d9d.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/040dc05418c817bb9bce756bd8a82a21.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe258b79cbaea3272c1452d43cc09f74.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8692bc1c3872cc584ddc32a8226f819b.webp",980,1385]